AAAAAA
Results:
1-15
|
Results: 15
Authors:
Vallot, F
Berghmans, T
Delhaye, F
Dagnelie, J
Sculier, JP
Citation: F. Vallot et al., Electrocardiographic manifestations of heart metastasis from a primary lung cancer, SUPP CARE C, 9(4), 2001, pp. 275-277
Authors:
Berghmans, T
Paesmans, M
Sculier, JP
Citation: T. Berghmans et al., The role of cisplatin in the treatment of small-cell lung cancer?, ANN ONCOL, 12(5), 2001, pp. 585-586
Authors:
Steels, E
Paesmans, B
Berghmans, T
Branle, F
Lemaitre, F
Mascaux, C
Meert, AP
Vallot, F
Lafitte, JJ
Sculier, JP
Citation: E. Steels et al., Role of p53 as a prognostic factor for survival in lung cancer: a systematic review of the literature with a meta-analysis, EUR RESP J, 18(4), 2001, pp. 705-719
Authors:
Berghmans, T
Paesmans, M
Sculier, JP
Citation: T. Berghmans et al., Cisplatin or carboplatin for the treatment of non-small cell lung cancer: do they have equivalent efficacy?, LUNG CANC, 34(1), 2001, pp. 15-17
Authors:
Sculier, JP
Ghisdal, L
Berghmans, T
Branle, F
Lafitte, JJ
Vallot, F
Meert, AP
Lemaitre, F
Steels, E
Burniat, A
Mascaux, C
Paesmans, M
Citation: Jp. Sculier et al., The role of mitomycin in the treatment of non small cell lung cancer: a systematic review with meta-analysis of the literature, BR J CANC, 84(9), 2001, pp. 1150-1155
Authors:
Berghmans, T
Paesmans, M
Body, JJ
Citation: T. Berghmans et al., A prospective study on hyponatraemia in medical cancer patients: epidemiology, aetiology and differential diagnosis, SUPP CARE C, 8(3), 2000, pp. 192-197
Authors:
Kip, BJ
Berghmans, T
Palmen, P
van der Pol, A
Huys, M
Hartwig, H
Scheepers, M
Wienke, D
Citation: Bj. Kip et al., On the use of recent developments in vibrational spectroscopic instrumentation in an industrial environment: quicker, smaller and more robust, VIB SPECTR, 24(1), 2000, pp. 75-92
Authors:
Mascaux, C
Paesmans, M
Berghmans, T
Branle, F
Lafitte, JJ
Lemaitre, F
Meert, AP
Vermylen, P
Sculier, JP
Citation: C. Mascaux et al., A systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis, LUNG CANC, 30(1), 2000, pp. 23-36
Authors:
Sculier, JP
Lafitte, JJ
Berghmans, T
Thiriaux, J
Lecomte, J
Efremidis, A
Ninane, V
Paesmans, M
Mommen, P
Klastersky, J
Citation: Jp. Sculier et al., A phase II trial testing gemcitabine as second-line chemotherapy for non small cell lung cancer, LUNG CANC, 29(1), 2000, pp. 67-73
Authors:
Sculier, JP
Paesmans, M
Markiewicz, E
Berghmans, T
Citation: Jp. Sculier et al., Scoring systems in cancer patients admitted for an acute complication in amedical intensive care unit, CRIT CARE M, 28(8), 2000, pp. 2786-2792
Authors:
Pierard, P
Vermylen, P
Bosschaerts, T
Roufosse, C
Berghmans, T
Sculier, JP
Ninane, V
Citation: P. Pierard et al., Synchronous roentgenographically occult lung carcinoma in patients with resectable primary lung cancer, CHEST, 117(3), 2000, pp. 779-785
Authors:
Sculier, JP
Lafitte, JJ
Paesmans, M
Thiriaux, J
Alexopoulos, CG
Baumohl, J
Schmerber, J
Koumakis, G
Florin, MC
Zacharias, C
Berghmans, T
Mommen, P
Ninane, V
Klastersky, J
Citation: Jp. Sculier et al., Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer, BR J CANC, 83(9), 2000, pp. 1128-1135
Authors:
Sculier, JP
Paesmans, M
Lafitte, JJ
Baumohl, J
Thiriaux, J
van Cutsem, O
Recloux, P
Bureau, G
Berchier, MC
Zacharias, C
Mommen, P
Bosschaerts, T
Berghmans, T
van Houtte, P
Ninane, V
Klastersky, J
Citation: Jp. Sculier et al., A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectablelocoregional non-small-cell lung cancer responding to induction chemotherapy, ANN ONCOL, 10(3), 1999, pp. 295-303
Authors:
Berghmans, T
Klastersky, J
Markiewicz, E
Mommen, P
Sculier, JP
Citation: T. Berghmans et al., Cisplatin-carboplatin-gemcitabine or ifosfamide-gemcitabine in advanced non-small cell lung carcinoma: Two pilot studies, ANTICANC R, 19(6C), 1999, pp. 5651-5655
Authors:
Meert, AP
Berghmans, T
Branle, F
Lemaitre, F
Mascaux, C
Rubesova, E
Vermylen, P
Paesmans, M
Sculier, JP
Citation: Ap. Meert et al., Phase II and III studies with new drugs for non-small cell lung cancer: A systematic review of the literature with a methodology quality assessment, ANTICANC R, 19(5C), 1999, pp. 4379-4390
Risultati:
1-15
|